Retinal Symposium

Audina Berrocal, M.D., is a pediatric retina specialist and world-leader in the medical and surgical management of retinopathy of prematurity and pediatric vitreoretinal disorders. Berrocal has been instrumental in the description and management of pediatric retinal disorders.  She has advanced the use of fluorescein angiography in pediatric vitreoretinal disorders improving outcomes.  She has also taken care of an inner-city neonatal Intensive Care Unit weekly for the past 20 years preventing blindness among the premature.  Furthermore, she has been the first surgeon to treat the youngest patient in the United States with the first FDA-approved gene therapy.  She has continued this novel, curative surgical treatment among children with Leber’s congenital amaurosis.  Not only is she a unique clinician and outstanding surgeon, but she devotes time to teaching and the support of women in the field of ophthalmology and retina. Dr. Berrocal was named to the Ophthalmologist Power List 2022.